Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Genetically decreased vitamin D and risk of Alzheimer disease.

Mokry LE, Ross S, Morris JA, Manousaki D, Forgetta V, Richards JB.

Neurology. 2016 Dec 13;87(24):2567-2574. Epub 2016 Nov 16.

2.

Vitamin D and Risk of Multiple Sclerosis: A Mendelian Randomization Study.

Mokry LE, Ross S, Ahmad OS, Forgetta V, Smith GD, Goltzman D, Leong A, Greenwood CM, Thanassoulis G, Richards JB.

PLoS Med. 2015 Aug 25;12(8):e1001866. doi: 10.1371/journal.pmed.1001866. eCollection 2015 Aug. Erratum in: PLoS Med. 2016 Mar;13(3):e1001981. Goltzman, David [added].

3.

Mendelian Randomization Studies Do Not Support a Role for Vitamin D in Coronary Artery Disease.

Manousaki D, Mokry LE, Ross S, Goltzman D, Richards JB.

Circ Cardiovasc Genet. 2016 Aug;9(4):349-56. doi: 10.1161/CIRCGENETICS.116.001396. Epub 2016 Jul 14.

4.

Vitamin D levels and susceptibility to asthma, elevated immunoglobulin E levels, and atopic dermatitis: A Mendelian randomization study.

Manousaki D, Paternoster L, Standl M, Moffatt MF, Farrall M, Bouzigon E, Strachan DP, Demenais F, Lathrop M, Cookson WOCM, Richards JB.

PLoS Med. 2017 May 9;14(5):e1002294. doi: 10.1371/journal.pmed.1002294. eCollection 2017 May.

5.

The causal effect of vitamin D binding protein (DBP) levels on calcemic and cardiometabolic diseases: a Mendelian randomization study.

Leong A, Rehman W, Dastani Z, Greenwood C, Timpson N, Langsetmo L, Berger C; METASTROKE, Fu L, Wong BY, Malik S, Malik R, Hanley DA, Cole DE, Goltzman D, Richards JB.

PLoS Med. 2014 Oct 28;11(10):e1001751. doi: 10.1371/journal.pmed.1001751. eCollection 2014 Oct.

6.

No clear support for a role for vitamin D in Parkinson's disease: A Mendelian randomization study.

Larsson SC, Singleton AB, Nalls MA, Richards JB; International Parkinson's Disease Genomics Consortium (IPDGC).

Mov Disord. 2017 Aug;32(8):1249-1252. doi: 10.1002/mds.27069. Epub 2017 Jun 8.

7.

Associations between Potentially Modifiable Risk Factors and Alzheimer Disease: A Mendelian Randomization Study.

Østergaard SD, Mukherjee S, Sharp SJ, Proitsi P, Lotta LA, Day F, Perry JR, Boehme KL, Walter S, Kauwe JS, Gibbons LE; Alzheimer’s Disease Genetics Consortium; GERAD1 Consortium; EPIC-InterAct Consortium, Larson EB, Powell JF, Langenberg C, Crane PK, Wareham NJ, Scott RA.

PLoS Med. 2015 Jun 16;12(6):e1001841; discussion e1001841. doi: 10.1371/journal.pmed.1001841. eCollection 2015 Jun.

8.

Examining the Causal Role of Leptin in Alzheimer Disease: A Mendelian Randomization Study.

Romo ML, Schooling CM.

Neuroendocrinology. 2017;105(2):182-188. doi: 10.1159/000475713. Epub 2017 Apr 19.

9.

Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts.

Vimaleswaran KS, Berry DJ, Lu C, Tikkanen E, Pilz S, Hiraki LT, Cooper JD, Dastani Z, Li R, Houston DK, Wood AR, Michaëlsson K, Vandenput L, Zgaga L, Yerges-Armstrong LM, McCarthy MI, Dupuis J, Kaakinen M, Kleber ME, Jameson K, Arden N, Raitakari O, Viikari J, Lohman KK, Ferrucci L, Melhus H, Ingelsson E, Byberg L, Lind L, Lorentzon M, Salomaa V, Campbell H, Dunlop M, Mitchell BD, Herzig KH, Pouta A, Hartikainen AL; Genetic Investigation of Anthropometric Traits-GIANT Consortium, Streeten EA, Theodoratou E, Jula A, Wareham NJ, Ohlsson C, Frayling TM, Kritchevsky SB, Spector TD, Richards JB, Lehtimäki T, Ouwehand WH, Kraft P, Cooper C, März W, Power C, Loos RJ, Wang TJ, Järvelin MR, Whittaker JC, Hingorani AD, Hyppönen E.

PLoS Med. 2013;10(2):e1001383. doi: 10.1371/journal.pmed.1001383. Epub 2013 Feb 5.

10.

Genetic predisposition to increased blood cholesterol and triglyceride lipid levels and risk of Alzheimer disease: a Mendelian randomization analysis.

Proitsi P, Lupton MK, Velayudhan L, Newhouse S, Fogh I, Tsolaki M, Daniilidou M, Pritchard M, Kloszewska I, Soininen H, Mecocci P, Vellas B; Alzheimer's Disease Neuroimaging Initiative, Williams J; GERAD1 Consortium, Stewart R, Sham P, Lovestone S, Powell JF.

PLoS Med. 2014 Sep 16;11(9):e1001713. doi: 10.1371/journal.pmed.1001713. eCollection 2014 Sep.

11.

Diabetic Phenotypes and Late-Life Dementia Risk: A Mechanism-specific Mendelian Randomization Study.

Walter S, Marden JR, Kubzansky LD, Mayeda ER, Crane PK, Chang SC, Cornelis M, Rehkopf DH, Mukherjee S, Glymour MM.

Alzheimer Dis Assoc Disord. 2016 Jan-Mar;30(1):15-20. doi: 10.1097/WAD.0000000000000128.

12.

Evaluation of genetic markers as instruments for Mendelian randomization studies on vitamin D.

Berry DJ, Vimaleswaran KS, Whittaker JC, Hingorani AD, Hyppönen E.

PLoS One. 2012;7(5):e37465. doi: 10.1371/journal.pone.0037465. Epub 2012 May 21.

13.

Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study.

Ong JS, Cuellar-Partida G, Lu Y; Australian Ovarian Cancer Study, Fasching PA, Hein A, Burghaus S, Beckmann MW, Lambrechts D, Van Nieuwenhuysen E, Vergote I, Vanderstichele A, Anne Doherty J, Anne Rossing M, Chang-Claude J, Eilber U, Rudolph A, Wang-Gohrke S, Goodman MT, Bogdanova N, Dörk T, Dürst M, Hillemanns P, Runnebaum IB, Antonenkova N, Butzow R, Leminen A, Nevanlinna H, Pelttari LM, Edwards RP, Kelley JL, Modugno F, Moysich KB, Ness RB, Cannioto R, Høgdall E, Høgdall CK, Jensen A, Giles GG, Bruinsma F, Kjaer SK, Hildebrandt MA, Liang D, Lu KH, Wu X, Bisogna M, Dao F, Levine DA, Cramer DW, Terry KL, Tworoger SS, Stampfer M, Missmer S, Bjorge L, Salvesen HB, Kopperud RK, Bischof K, Aben KK, Kiemeney LA, Massuger LF, Brooks-Wilson A, Olson SH, McGuire V, Rothstein JH, Sieh W, Whittemore AS, Cook LS, Le ND, Gilks CB, Gronwald J, Jakubowska A, Lubiński J, Kluz T, Song H, Tyrer JP, Wentzensen N, Brinton L, Trabert B, Lissowska J, McLaughlin JR, Narod SA, Phelan C, Anton-Culver H, Ziogas A, Eccles D, Campbell I, Gayther SA, Gentry-Maharaj A, Menon U, Ramus SJ, Wu AH, Dansonka-Mieszkowska A, Kupryjanczyk J, Timorek A, Szafron L, Cunningham JM, Fridley BL, Winham SJ, Bandera EV, Poole EM, Morgan TK, Risch HA, Goode EL, Schildkraut JM, Pearce CL, Berchuck A, Pharoah PD, Chenevix-Trench G, Gharahkhani P, Neale RE, Webb PM, MacGregor S.

Int J Epidemiol. 2016 Oct;45(5):1619-1630. Epub 2016 Sep 4.

14.

Genetically-Predicted Adult Height and Alzheimer's Disease.

Larsson SC, Traylor M, Burgess S, Markus HS.

J Alzheimers Dis. 2017;60(2):691-698. doi: 10.3233/JAD-170528.

15.

Genetically predicted body mass index and Alzheimer's disease-related phenotypes in three large samples: Mendelian randomization analyses.

Mukherjee S, Walter S, Kauwe JSK, Saykin AJ, Bennett DA, Larson EB, Crane PK, Glymour MM; Adult Changes in Thought Study Investigators; Religious Orders Study/Memory and Aging Project Investigators; Alzheimer's Disease Genetics Consortium.

Alzheimers Dement. 2015 Dec;11(12):1439-1451. doi: 10.1016/j.jalz.2015.05.015. Epub 2015 Jun 12.

16.

Circulating Serum 25-Hydroxyvitamin D Levels and Bone Mineral Density: Mendelian Randomization Study.

Larsson SC, Melhus H, Michaëlsson K.

J Bone Miner Res. 2018 May;33(5):840-844. doi: 10.1002/jbmr.3389. Epub 2018 Feb 9.

PMID:
29338102
17.

Obesity and Multiple Sclerosis: A Mendelian Randomization Study.

Mokry LE, Ross S, Timpson NJ, Sawcer S, Davey Smith G, Richards JB.

PLoS Med. 2016 Jun 28;13(6):e1002053. doi: 10.1371/journal.pmed.1002053. eCollection 2016 Jun.

18.

Association between circulating 25-hydroxyvitamin D and incident type 2 diabetes: a mendelian randomisation study.

Ye Z, Sharp SJ, Burgess S, Scott RA, Imamura F; InterAct Consortium, Langenberg C, Wareham NJ, Forouhi NG.

Lancet Diabetes Endocrinol. 2015 Jan;3(1):35-42. doi: 10.1016/S2213-8587(14)70184-6. Epub 2014 Sep 30. Erratum in: Lancet Diabetes Endocrinol. 2015 Jan;3(1):e1.

19.

Large differences in adiponectin levels have no clear effect on multiple sclerosis risk: A Mendelian randomization study.

Devorak J, Mokry LE, Morris JA, Forgetta V, Davey Smith G, Sawcer S, Richards JB.

Mult Scler. 2017 Oct;23(11):1461-1468. doi: 10.1177/1352458516681196. Epub 2016 Dec 7.

PMID:
27903934
20.

No evidence that genetically reduced 25-hydroxyvitamin D is associated with increased risk of ischaemic heart disease or myocardial infarction: a Mendelian randomization study.

Brøndum-Jacobsen P, Benn M, Afzal S, Nordestgaard BG.

Int J Epidemiol. 2015 Apr;44(2):651-61. doi: 10.1093/ije/dyv078. Epub 2015 May 16.

PMID:
25981321

Supplemental Content

Support Center